190 related articles for article (PubMed ID: 37206220)
1. Neuroprotective effect of engineered
Wang Y; Chen WJ; Han YY; Xu X; Yang AX; Wei J; Hong DJ; Fang X; Chen TT
Bioeng Transl Med; 2023 May; 8(3):e10505. PubMed ID: 37206220
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
[TBL] [Abstract][Full Text] [Related]
3. Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models.
Wang XL; Chen WJ; Jin R; Xu X; Wei J; Huang H; Tang YH; Zou CW; Chen TT
Microb Biotechnol; 2023 Apr; 16(4):799-812. PubMed ID: 36528874
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of an engineered
Wu H; Wei J; Zhao X; Liu Y; Chen Z; Wei K; Lu J; Chen W; Jiang M; Li S; Chen T
Bioeng Transl Med; 2023 Sep; 8(5):e10351. PubMed ID: 37693045
[TBL] [Abstract][Full Text] [Related]
5. Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis.
Li H; Sun J; Du J; Wang F; Fang R; Yu C; Xiong J; Chen W; Lu Z; Liu J
Neurogastroenterol Motil; 2018 May; 30(5):e13260. PubMed ID: 29193450
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease.
Fang X; Zhou X; Miao Y; Han Y; Wei J; Chen T
AMB Express; 2020 Apr; 10(1):80. PubMed ID: 32333225
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic Role of the Next-Generation Probiotic Strain
Yue M; Wei J; Chen W; Hong D; Chen T; Fang X
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432569
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson's Disease Mouse Model.
Zhang Z; Hao L; Shi M; Yu Z; Shao S; Yuan Y; Zhang Z; Hölscher C
J Parkinsons Dis; 2021; 11(2):529-543. PubMed ID: 33523018
[TBL] [Abstract][Full Text] [Related]
10. Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
Liu X; Liu W; Wang C; Chen Y; Liu P; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Physiol Behav; 2021 Oct; 239():113510. PubMed ID: 34181930
[TBL] [Abstract][Full Text] [Related]
11. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Can Enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD Mice Model by Activating AMPK.
Chen C; Chen Y; Liu T; Song D; Ma D; Cheng O
Oxid Med Cell Longev; 2022; 2022():7511393. PubMed ID: 35528513
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects.
Sayehmiri F; Samadian M; Mohamadkhani A; Tafakhori A; Haghighat S; Rahmatian A; Mohammadkhani MA; Fazli HR; Rezaei Tavirani M
Middle East J Dig Dis; 2022 Apr; 14(2):235-243. PubMed ID: 36619150
[No Abstract] [Full Text] [Related]
14. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.
Zhang L; Zhang L; Li L; Hölscher C
Neuropeptides; 2018 Oct; 71():70-80. PubMed ID: 30017231
[TBL] [Abstract][Full Text] [Related]
16. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
Zhang L; Zhang L; Li L; Hölscher C
J Parkinsons Dis; 2019; 9(1):157-171. PubMed ID: 30741689
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling.
Mao Z; Hui H; Zhao X; Xu L; Qi Y; Yin L; Qu L; Han L; Peng J
J Pharm Anal; 2023 Oct; 13(10):1153-1167. PubMed ID: 38024855
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress.
Lin TK; Lin KJ; Lin HY; Lin KL; Lan MY; Wang PW; Wang TJ; Wang FS; Tsai PC; Liou CW; Chuang JH
Front Mol Neurosci; 2021; 14():697440. PubMed ID: 34305527
[TBL] [Abstract][Full Text] [Related]
19. Clostridium butyricum Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behavior in Mice via the Gut-Brain Axis.
Sun J; Wang F; Hu X; Yang C; Xu H; Yao Y; Liu J
J Agric Food Chem; 2018 Aug; 66(31):8415-8421. PubMed ID: 30040410
[TBL] [Abstract][Full Text] [Related]
20. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C
Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
